VitaminLab, a healthtech company developing personalized supplements, closed a Series A investment round co-led by Canadian healthtech venture fund Nimbus Synergies and DSM Venturing, the corporate startup arm of multinational health and nutrition corporation Royal DSM.

The company creates personalized supplements for individuals, using data points such as one’s health history, blood test results, and DNA. A proprietary process formulates a unique vitamin for each person, which is sold direct-to-consumer via e-commerce.

"Our mission is to redefine the status quo and unlock better health outcomes by transforming how we take vitamins through tailored and truly unique formulas," said Anton Solonnikov, CEO of VitaminLab. "This financing allows us to extend our leadership position by further investing in our technology and expanding our sales and marketing into the practitioner market and new areas of growth."

Solonnikov worked as a pharmacist for over 10 years before founding VitaminLab. The company now staffs over 40 employees, and formulates, tests, and produces its products in Victoria.

"VitaminLab's disruptive approach is revolutionizing the personalized nutrition industry and we are thrilled to continue supporting its positive impact on consumer health," said Paul Geyer, CEO of Nimbus Synergies.

The funding will expand the company’s facilities and automation, as well as scale its go-to-market strategy across North America.